Advanced Biomed Inc. Common Stock

ADVBNASDAQHealthcare● Active

$3.94

$-0.23(-5.52%)

Market Cap$4263557

P/E Ratio—

52W High$19.72

52W Low$3.61

Avg Volume456K

Open$4.17

Beta0.69

Overview

Advanced Biomed Inc. Common Stock (ADVB) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

advb · pe ratio · data through Jun 30, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Advanced Biomed Inc. Common Stock (ADVB) measures how much investors pay for each dollar of the company's trailing earnings. ADVB's current PE ratio of N/A is calculated by dividing its stock price of $3.94 by its TTM earnings per share of -$0.53.

N/A

P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30

Forward P/E

N/A

—

EPS (TTM)

-$0.53

TTM · diluted EPS

PEG Ratio

-0.02

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Advanced Biomed Inc. Common Stock SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2021 – 2025 · Annual

PE Ratio (TTM)

EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Diagnostics & Research · 6 peers · Annual PE

Company	Market Cap	PE (Annual)	vs Avg	EPS (TTM)
Advanced Biomed Inc. Common StockYou ADVB	$4M	N/A	—	-$0.53
Aptorum Group Limited APM	$7M	N/A	—	-$0.19
BioNexus Gene Lab Corp. BGLC	$4M	N/A	—	-$1.61
Check-Cap Ltd. CHEK	$11M	N/A	—	-$4.30
Gelteq Limited Ordinary Shares GELS	$4M	N/A	—	$0.00
Mustang Bio, Inc. MBIO	$5M	N/A	—	-$0.39
Marker Therapeutics, Inc. MRKR	$16M	N/A	—	-$0.79

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years

Fiscal Year End	PE Ratio	EPS (TTM)	YoY Change
2025-06-30Latest FY2025	—	$-0.09	—
2024-06-30 FY2024	—	$-2.57	—
2023-06-30 FY2023	—	$-0.11	—
2022-06-30 FY2022	—	$-3.72	—
2021-06-30 FY2021	—	$-1.70	—

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

PE Ratio = Stock Price ÷ EPS (TTM)

= $3.94 ÷ -$0.53 = N/A

TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures

Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year

PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium

Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Price history Financial statements Earnings

Frequently asked questions

ADVB pe ratio · 6 questions

ADVB's current PE ratio is N/A as of 2026-06-09, based on a stock price of $3.94 and TTM EPS of -$0.53. Data sourced from Financial Modeling Prep via ADVB's SEC 10-K and 10-Q filings.

ADVB PE ratioWhat is ADVB PE ratioCurrent PE ratio of ADVBADVB PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Advanced Biomed Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09